
Medaplus Pharmaceuticals Private Limited
About Medaplus Pharmaceuticals Private Limited
Data last updated:
Medaplus Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 29 November 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U46497UP2023PTC193211.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sahiba Nasrin and Sadiq Hussain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lucknow, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.99 Lakh. For the same year it recorded a net profit of ₹58,236 (net margin 7.3%) and EBITDA of ₹71,429 (EBITDA margin 8.9%).
Company details
Contact details
Medaplus Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered Address647 – B/A/56, Jankipuram Garden, Lucknow, Uttar Pradesh, India – 226021
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medaplus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medaplus Pharmaceuticals Private Limited, buy the company report.
Financials of Medaplus Pharmaceuticals Private Limited
FY 2025 filings availableMedaplus Pharmaceuticals Private Limited reported revenue of ₹7.99 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹71,429 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹58,236 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 8.9% | |
| Net Profit Margin | 7.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Medaplus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medaplus Pharmaceuticals Private Limited
Medaplus Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sahiba Nasrin | Director | 29 Nov 2023 | 2 Years 11 Months | Current |
| Sadiq Hussain | Director | 29 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Medaplus Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Becure Pharmaceuticals Private Limited | ₹8.09 Lakh (FY 2024) | 58.0% | New Delhi, Delhi, India | |||
| Arisha Pharmaceuticals (OPC) Private Limited | ₹8.07 Lakh (FY 2025) | 26.0% | Raiganj, West Bengal, India | |||
| Ojas Drugs & Pharmaceuticals Private Limited | ₹8.01 Lakh (FY 2024) | -52.0% | Dehradun, Uttarakhand, India | |||
| Medaplus Pharmaceuticals Private Limitedthis company | ₹7.99 Lakh (FY 2025) | ₹58,236 | 7.3% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Medaplus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medaplus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medaplus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medaplus Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medaplus Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Sadiq Hussain was appointed as Director on 29 Nov 2023.
Frequently asked questions
Medaplus Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 29 November 2023 (3+ years old) and is registered under CIN U46497UP2023PTC193211.
Medaplus Pharmaceuticals has 2 current directors:
- Sahiba Nasrin - Director
- Sadiq Hussain - Director
The latest financial statements of Medaplus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Medaplus Pharmaceuticals is U46497UP2023PTC193211. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medaplus Pharmaceuticals was incorporated on 29 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Medaplus Pharmaceuticals by revenue are Becure Pharmaceuticals Private Limited, Arisha Pharmaceuticals (OPC) Private Limited, Ojas Drugs & Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sadiq Hussain was appointed as Director on 29 Nov 2023. Sahiba Nasrin was appointed as Director on 29 Nov 2023.
The registered office of Medaplus Pharmaceuticals is at 647 – BA56, Jankipuram Garden, Lucknow, Uttar Pradesh, India – 226021.
Medaplus Pharmaceuticals can be reached at its registered office: 647 – BA56, Jankipuram Garden, Lucknow, Uttar Pradesh, India – 226021.
Medaplus Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.

